PM360

JUNE 24, 2024

As we enter into the age of precision medicine, AI will be a critical tool to determine, with the help of disease knowledge graphs, which indications, associations, contraindications, side effects, genetic markers, drug targets, drug carriers, and interactions to take into account on a case-by-case basis.

Healthcare 52

Healthcare Healthcare Patients Side effects 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.

Specialization 45

Specialization Leads Pharma Side effects 45

Medgadget

FEBRUARY 17, 2023

Moreover, the required training to get proficient with the device is only a few hours, unlike two weeks or more for the da Vinci. ” An attractive proposition in a world in which technology has contributed significantly to the distancing of physicians from their patients, usually leading to negative side effects. .”

Physicians 80

Physicians Engineering Leads Side effects 80

PM360

OCTOBER 22, 2024

DANNY SIGURDSON CEO and Founder Courier Health To effectively engage patients and prescribers to improve overall adherence to prescribed medication regimens, biopharma companies first need the visibility and full context of where a patient stands in their treatment journey. print, online, video). Advocate for policy change.

Education 52

Education Side effects Medical Patients 52

The Marketing Advantage

MAY 8, 2023

Recall from the earlier section that one of the primary roles of a rare disease sales force is not just education on the product and its efficacy, side effects, etc., This calls for a more specialized and expert sales force, requiring longer and more rigorous hiring and training processes.

Sales 52

Sales Physicians Consulting Education 52

Clarivate

OCTOBER 19, 2023

Drug candidates have a high rate of failure, as only 10% of de-novo drugs put through clinical trials finally obtain market approval, with the highest rate of attrition occurring at phase I and II of clinical trials (assessing safety, tolerability, dosage, efficacy, and side effects).

Networking 59

Networking Consulting Safety Side effects 59

PM360

JUNE 11, 2022

Be clear in your governance documents and training to level set expectations. Regardless of the tactics and strategies employed, I would encourage more biopharma professionals to get personally involved in patient engagement programs. For example, everyone must be steeped in both FDA and FTC guidelines.

Patients 59

Patients Pharma Education Media 59